Related Experiment Videos
Summary
Angio-immunoblastic lymphadenopathy (AILD) is a rare disorder with poor prognosis. This case report details its clinical and pathological features, highlighting key diagnostic findings and treatment approaches.
Area of Science:
- Immunology
- Oncology
- Pathology
Background:
- Angio-immunoblastic lymphadenopathy (AILD) is an aggressive non-Hodgkin lymphoma.
- It is characterized by systemic symptoms and lymphadenopathy.
Observation:
- A case of AILD involving the tonsils is presented.
- The patient exhibited fever, pruritus, rash, generalized lymphadenopathy, and hepatosplenomegaly.
- Histological examination revealed characteristic features including arborizing vessels and immunoblast proliferation.
Findings:
- Laboratory results showed polyclonal hyperglobulinemia and hemolytic anemia.
- The histological triad of vascular proliferation, immunoblasts, and interstitial material confirmed the diagnosis.
- Treatment involved corticosteroids and supportive care.
Implications:
- AILD generally has a poor prognosis with a median survival of 13 months.
- The etiology of AILD remains unknown, necessitating further research.
- Understanding these findings aids in diagnosis and management of AILD.